Personal Home Page

http://hsc.usf.edu/COM/iop/cancer/haura.html

Articles in Scholarly Journals [Incomplete List]

1. Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older
   Cancer, vol. 112, no. 9, pp. 2021–2029, 2008
2. Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
   Clinical Cancer Research, vol. 14, no. 5, pp. 1464–1469, 2008
3. Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor dependent human lung cancer cells
   Molecular Cancer Therapeutics, vol. 6, no. 9, pp. 2515–2524, 2007
4. Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy in Advanced Non-Small-Cell Lung Cancer
   Journal of Clinical Oncology, vol. 25, no. 19, pp. 2741–2746, 2007
5. A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells
   Cancer Chemotherapy and Pharmacology, vol. 61, no. 3, pp. 525–534, 2007
6. Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors
   Cancer, vol. 109, no. 7, pp. 1413–1419, 2007
7. DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer
   New England Journal of Medicine, vol. 356, no. 8, pp. 800–808, 2007
8. Effects of IFN-
   Journal of Interferon & Cytokine Research, vol. 27, no. 3, pp. 209–220, 2007
9. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin
   Proceedings of the National Academy of Sciences, vol. 103, no. 16, pp. 6332–6337, 2006
10. SRC and STAT Pathways
    Journal of Thoracic Oncology, vol. 1, no. 5, pp. 403–405, 2006
11. Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination?
    Medical Hypotheses, vol. 67, no. 4, pp. 951–956, 2006
12. Dasatinib (BMS-354825) Selectively Induces Apoptosis in Lung Cancer Cells Dependent on Epidermal Growth Factor Receptor Signaling for Survival
    Cancer Research, vol. 66, no. 11, pp. 5542–5548, 2006
13. Nicotine induces cell proliferation by  -arrestin-mediated activation of Src and Rb-Raf-1 pathways
    Journal of Clinical Investigation, vol. 116, no. 8, pp. 2208–2217, 2006
14. Nicotine induces cell proliferation by  -arrestin-mediated activation of Src and Rb-Raf-1 pathways
    Journal of Clinical Investigation, vol. 116, no. 11, pp. 3083–3083, 2006
15. BMC Genomics, vol. 7, no. 1, p. 289, 2006
16. Activated Epidermal Growth Factor Receptor-Stat-3 Signaling Promotes Tumor Survival In vivo in Non-Small Cell Lung Cancer
    Clinical Cancer Research, vol. 11, no. 23, pp. 8288–8294, 2005
17. Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer
    Oncology, vol. 68, no. 4-6, pp. 382–390, 2005
18. Small Tumor Size and Limited Smoking History Predicts Activated Epidermal Growth Factor Receptor in Early-Stage Non-small Cell Lung Cancer
    Chest, vol. 128, no. 1, pp. 308–316, 2005
19. EGR1 Predicts PTEN and Survival in Patients With Non-Small-Cell Lung Cancer
    Journal of Clinical Oncology, vol. 23, no. 9, pp. 1921–1926, 2005
20. Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer
    Nature Clinical Practice Oncology, vol. 2, no. 6, Article ID ncponc0195, 9 pages, 2005
21. Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance
    Lung Cancer, vol. 47, no. 2, pp. 183–192, 2005
22. Stat3 regulates genes common to both wound healing and cancer
    Oncogene, vol. 24, no. 21, Article ID 1208469, 11 pages, 2005
23. Re: Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia
    CancerSpectrum Knowledge Environment, vol. 97, no. 14, pp. 1088–1089, 2005
24. Neutropenic enterocolitis (typhilitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature
    Lung Cancer, vol. 44, no. 3, pp. 381–390, 2004
25. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer
    Lung Cancer, vol. 46, no. 3, pp. 313–323, 2004
26. RRM1 and PTEN As Prognostic Parameters for Overall and Disease-Free Survival in Patients With Non-Small-Cell Lung Cancer
    Journal of Clinical Oncology, vol. 22, no. 10, pp. 1878–1885, 2004
27. Gene Therapy for Lung Cancer
    Molecular Biotechnology, vol. 25, no. 2, pp. 139–148, 2003
28. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells
    Oncogene, vol. 22, no. 27, Article ID 1206479, 15 pages, 2003
29. p27Kip1 and p21Cip1 Are Not Required for the Formation of Active D Cyclin-cdk4 Complexes
    Molecular and Cellular Biology, vol. 23, no. 20, pp. 7285–7290, 2003
30. Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation
    Journal of Biological Chemistry, vol. 276, no. 48, pp. 45443–45455, 2001
31. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
    Genes & Development, vol. 14, no. 19, pp. 2501–2514, 2000